Related Experiment Video
Updated: Feb 18, 2026

11:04
Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
3.5K
3,7-Dideazaneplanocin: Synthesis and antiviral analysis
Xue-Qiang Yin1, Stewart W Schneller1
1Department of Chemistry and Biochemistry, Molette Laboratory for Drug Discovery, Auburn University, Auburn, USA.
Antiviral Chemistry & Chemotherapy
|November 28, 2017
Summary
Researchers synthesized 3,7-dideazaneplanocin to test its antiviral capabilities. Despite a successful synthesis, the compound showed no antiviral activity against DNA or RNA viruses in vitro.
Area of Science:
- Medicinal Chemistry
- Virology
- Organic Synthesis
Background:
- Adenine-based carbocyclic nucleosides, such as neplanocin, are investigated for their antiviral potential.
- Specific structural features are crucial for the antiviral activity of these compounds.
Purpose of the Study:
- To synthesize the novel compound 3,7-dideazaneplanocin.
- To evaluate the in vitro antiviral activity of 3,7-dideazaneplanocin against a range of DNA and RNA viruses.
Main Methods:
- A five-step synthetic route was employed to prepare 3,7-dideazaneplanocin from a cyclopentenol precursor.
- Standard antiviral assays were utilized to assess the compound's efficacy against various viruses.
Main Results:
- The synthesis of 3,7-dideazaneplanocin was successfully achieved and adaptable for analog synthesis.
- No antiviral activity was detected for 3,7-dideazaneplanocin in the conducted in vitro assays.
Conclusions:
- The absence of antiviral activity is attributed to the lack of essential structural features in 3,7-dideazaneplanocin.
- Key features for antiviral properties in related nucleosides include N-7 for S-adenosylhomocysteine hydrolase inhibition and N-3 for C-5' phosphorylation, which are absent in the synthesized compound.

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)